LFCR
$4.02-0.04 (-0.99%)
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.
Recent News
Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029
Lifecore Biomedical (NASDAQ:LFCR) CEO Paul Josephs told investors at a KeyBanc conference that the company has completed its transition into a “standalone CDMO” after divesting its former food businesses in 2022 and 2023. Josephs said Lifecore is now focused on two primary operations at its single s
Lifecore Biomedical Inc (LFCR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Lifecore Biomedical Inc (LFCR) reports a 10% revenue increase in Q4 2025 and outlines strategic initiatives to drive future growth despite anticipated challenges.
Lifecore Biomedical Q4 Earnings Call Highlights
Lifecore Biomedical (NASDAQ:LFCR) used its fiscal fourth-quarter earnings call to highlight revenue growth, improving margins, and continued cost reductions during its transition to a calendar-year reporting cycle. Management also discussed progress on commercial milestones tied to its largest custo
What Contributes to Lifecore Biomedical’s (LFCR) Distinct Competitive Advantage?
Laughing Water Capital, an investment management company, released its fourth-quarter 2025 investor letter. In the quarter, Laughing Water Capital returned ~6.8%, bringing the full-year returns to ~3.9% net of fees and expenses. In comparison, the SP500TR and R2000 returned approximately 2.7% and 2.2%, respectively, in the quarter, and finished the year up by 17.9% and […]
One Lifecore Biomedical Insider Raised Their Stake In The Previous Year
From what we can see, insiders were net buyers in Lifecore Biomedical, Inc.'s ( NASDAQ:LFCR ) during the past 12...